Yue-Tong Chen

Mr. Yue-Tong Chen

Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
SASabrina Ayoub-Charette
Sabrina Ayoub-Charette
NMNéma D. McGlynn
Néma D. McGlynn
DLDanielle Lee
Danielle Lee
TKTauseef Khan
Tauseef Khan
SMSonia Blanco Mejia
Sonia Blanco Mejia
John SievenpiperJohn Sievenpiper
John Sievenpiper
Background: Health authorities are near universal in their recommendation to replace sugar-sweetened beverages (SSBs) with water. Non-nutritive sweetened beverages (NSBs) are not as widely recommended as a replacement strategy due to a lack of established benefits and concerns they may induce glucose intolerance through changes in the gut microbiome. The STOP Sugars NOW trial aims to assess the effect of the substitution of NSBs (the “intended substitution”) versus water (the “standard of care substitution”) for SSBs on glucose tolerance and microbiota diversity. Design and Methods: The STOP Sugars NOW trial (NCT03543644) is a pragmatic, “head-to-head”, open-label, crossover, randomized controlled trial conducted in an outpatient setting. Participants were overweight or obese adults with a high waist circumference who regularly consumed ≥1 SSBs daily. Each participant completed three 4-week treatment phases (usual SSBs, matched NSBs, or water) in random order, which were separated by ≥4-week washout. Blocked randomization was performed centrally by computer with allocation concealment. Outcome assessment was blinded; however, blinding of participants and trial personnel was not possible. The two primary outcomes are oral glucose tolerance (incremental area under the curve) and gut microbiota beta-diversity (weighted UniFrac distance). Secondary outcomes include related markers of adiposity and glucose and insulin regulation. Adherence was assessed by objective biomarkers of added sugars and non-nutritive sweeteners and self-report intake. A subset of participants was included in an Ectopic Fat sub-study in which the primary outcome is intrahepatocellular lipid (IHCL) by 1H-MRS. Analyses will be according to the intention to treat principle. Baseline results: Recruitment began on 1 June 2018, and the last participant completed the trial on 15 October 2020. We screened 1086 participants, of whom 80 were enrolled and randomized in the main trial and 32 of these were enrolled and randomized in the Ectopic Fat sub-study. The participants were predominantly middle-aged (mean age 41.8 ± SD 13.0 y) and had obesity (BMI of 33.7 ± 6.8 kg/m2) with a near equal ratio of female: male (51%:49%). The average baseline SSB intake was 1.9 servings/day. SSBs were replaced with matched NSB brands, sweetened with either a blend of aspartame and acesulfame-potassium (95%) or sucralose (5%). Conclusions: Baseline characteristics for both the main and Ectopic Fat sub-study meet our inclusion criteria and represent a group with overweight or obesity, with characteristics putting them at risk for type 2 diabetes. Findings will be published in peer-reviewed open-access medical journals and provide high-level evidence to inform clinical practice guidelines and public health policy for the use NSBs in sugars reduction strategies. Trial registration: ClinicalTrials.gov identifier, NCT03543644.

1 November 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
SYShuting Yang
Shuting Yang
SBSonghee Back
Songhee Back
SGShannan M Grant
Shannan M Grant
SASabrina Ayoub-Charette
Sabrina Ayoub-Charette
VCVictoria Chen
Victoria Chen
Laura ChiavaroliLaura Chiavaroli
Laura Chiavaroli
Background: Many clinical practice guidelines recommend dietary pulses for the prevention and management of cardiovascular disease and diabetes. The impact of extracted pulse proteins remains unclear. We therefore conducted a systematic review and meta-analysis of randomized controlled trials of the effect of extracted pulse proteins on therapeutic lipid targets. Methods and Findings: MEDLINE, Embase, and the Cochrane Library were searched through April 2024 for trials of ≥3-weeks. The primary outcome was low-density lipoprotein-cholesterol (LDL-C). The secondary outcomes were other lipid targets. Independent reviewers extracted data and assessed the risk of bias. Subgroup analyses included by pulse type and the certainty of evidence was assessed using GRADE. Results: Seven included trials (14 trial comparisons, n = 453) with a median of 4-weeks duration and dose of 35 g/day showed that extracted pulse proteins decreased LDL-C by −0.23 mmol/L (95% confidence interval: −0.36 to −0.10 mmol/L, p < 0.001). Similar effects were observed for non-high-density lipoprotein-cholesterol and apolipoprotein B. No interactions were found by pulse type. Subgroup analyses revealed effect modification by sex, with greater proportions of females seeing greater reductions. GRADE was generally moderate. Conclusions: Extracted pulse proteins likely result in moderate reductions in LDL-C and other lipid targets. Future studies on various types of extracted pulse proteins including assessments by sex are warranted.

18 November 2025 in Food & Function
Verified
Journal Article
Open access
PDF file
MKMichelle Ku
Michelle Ku
ATAmel Taibi
Amel Taibi
DWDiana Wu
Diana Wu
YCYue-Tong Chen
Yue-Tong Chen
LLLorena Lopez-Dominguez
Lorena Lopez-Dominguez
ECElena M Comelli
Elena M Comelli
Gut microbiota structure, rather than composition, is linked with serum enterolignans concentration response to dietary flaxseed hull vs. flaxseed. Created with BioRender.

19 May 2026 in Journal of the American Heart Association
Verified
Journal Article
Closed access
SBSonghee Back
Songhee Back
SYShuting Yang
Shuting Yang
ARAntonio Rossi
Antonio Rossi
SASabrina Ayoub-Charette
Sabrina Ayoub-Charette
SGShannan M Grant
Shannan M Grant
Laura ChiavaroliLaura Chiavaroli
Laura Chiavaroli
Background: Although dietary pulses are recognized by major clinical practice guidelines to reduce cholesterol and coronary heart disease risk, intake is low. There are no health claims for any pulse for cholesterol reduction, which could support uptake. We therefore conducted a systematic review and dose–response meta‐analysis of randomized trials of the effect of different types of whole dietary pulses on lipid targets. Methods: MEDLINE, Embase, and the Cochrane Library were searched through March 2025 for trials ≥3 weeks. The primary outcome was low‐density lipoprotein‐cholesterol. Secondary outcomes were other lipid targets. Independent reviewers extracted data and assessed risk of bias. Certainty of evidence was assessed using Grading of Recommendations Assessment, Development, and Evaluation. Results: Thirty‐eight trials (52 trial comparisons, n=2095) with a median of 6 weeks and dose of 130 g/d (0.5–0.67 cup/d) showed that whole dietary pulses decreased low‐density lipoprotein‐cholesterol (mean difference, −0.14 mmol/L [95% CI, −0.19 to −0.08]), non‐high‐density lipoprotein‐cholesterol (−0.22 mmol/L [95% CI, −0.30 to −0.14]), apoB (apolipoprotein B) (−0.08 g/L [95% CI, −0.13 to −0.03]) and high‐density lipoprotein‐cholesterol (−0.03 mmol/L [95% CI, −0.05 to −0.01]) with no effects on other lipids. Analyses by pulse type showed similar results. A linear inverse relationship was shown for beans up to 1 cup/d for low‐density lipoprotein‐cholesterol (coefficient, −0.25 mmol/L/0.5 cup [95% CI, −0.48 to −0.02]) and non‐high‐density lipoprotein‐cholesterol (−0.45 mmol/L/0.5 cup [95% CI, −0.71 to −0.18]). Grading of Recommendations Assessment, Development, and Evaluation was moderate‐to‐high for all outcomes, except apoB (very low). Conclusions: Whole dietary pulses likely result in small important‐to‐moderate reductions in lipid targets and trivial reductions in high‐density lipoprotein‐cholesterol. Similar effects were observed across pulse types with an inverse dose–response gradient for beans up to 1 cup/d. Future studies on chickpeas, dried peas, and lentils are warranted. Registration: URL: https://www.crd.york.ac.uk/PROSPERO/view/CRD42023432826 ; Unique identifier: CRD42023432826.